HIN 0.00% $2.37 heartware international, inc

dirty dealing

  1. 228 Posts.
    LOUISVILLE, KY (WAVE) - A complaint filed against University of Louisville and Jewish Hospitals has been dismissed.

    The Food and Drug Administration found no wrong doing by doctors conducting a clinical study.

    The FDA was conducting an audit on the heartware bridge to transplant study.

    The audit completed on Nov. 8 found no fault with protocol and the initial complaint has been discharged.

    www.wave3.com/story/13467299/complaint-against-ul-jewish-hospitals-dismissed-by-fda
 
watchlist Created with Sketch. Add HIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.